2022
DOI: 10.1016/j.eplepsyres.2022.107028
|View full text |Cite
|
Sign up to set email alerts
|

EEG parameters as endpoints in epilepsy clinical trials - An expert panel opinion paper

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 83 publications
0
2
0
Order By: Relevance
“…The results indicate that the features that we extracted from the EEG signal are more affected by seizure propensity (risk of having seizure recurrence) than past seizures. Ultimately, all these outcomes depend on the imperfect reporting of seizures by patients 50 ; there is promise that in the future, more objective outcomes could directly benefit predictive models in epilepsy 51 .…”
Section: Discussionmentioning
confidence: 99%
“…The results indicate that the features that we extracted from the EEG signal are more affected by seizure propensity (risk of having seizure recurrence) than past seizures. Ultimately, all these outcomes depend on the imperfect reporting of seizures by patients 50 ; there is promise that in the future, more objective outcomes could directly benefit predictive models in epilepsy 51 .…”
Section: Discussionmentioning
confidence: 99%
“…Long-term automated counting of GPFA events may have potential benefit for the prediction of seizure events or titration of therapies, as has been demonstrated in other epilepsies [26][27][28] . Furthermore, there is increasing interest in the use of EEG measurements as trial endpoints for studying the effects of interventions, which would benefit immensely from automated review processes 21 .…”
Section: Discussionmentioning
confidence: 99%